Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology by Zhang, L. et al.
JOURNAL OF VIROLOGY, June 2002, p. 5654–5666 Vol. 76, No. 11
0022-538X/02/$04.000 DOI: 10.1128/JVI.76.11.5654–5666.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Respiratory Syncytial Virus Infection of Human Airway Epithelial
Cells Is Polarized, Specific to Ciliated Cells, and without
Obvious Cytopathology
Liqun Zhang,1* Mark E. Peeples,2 Richard C. Boucher,1 Peter L. Collins,3 and Raymond J. Pickles1
Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, North Carolina 27599-72481;
Department of Immunology/Microbiology, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois 606122; and Laboratory of
Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health,
Bethesda, Maryland 20892-07203
Received 16 November 2001/Accepted 21 February 2002
Gene therapy for cystic fibrosis (CF) lung disease requires efficient gene transfer to airway epithelial cells
after intralumenal delivery. Most gene transfer vectors so far tested have not provided the efficiency required.
Although human respiratory syncytial virus (RSV), a common respiratory virus, is known to infect the
respiratory epithelium, the mechanism of infection and the epithelial cell type targeted by RSV have not been
determined. We have utilized human primary airway epithelial cell cultures that generate a well-differentiated
pseudostratified mucociliary epithelium to investigate whether RSV infects airway epithelium via the lumenal
(apical) surface. A recombinant RSV expressing green fluorescent protein (rgRSV) infected epithelial cell
cultures with high gene transfer efficiency when applied to the apical surface but not after basolateral
inoculation. Analyses of the cell types infected by RSV revealed that lumenal columnar cells, specifically
ciliated epithelial cells, were targeted by RSV and that cultures became susceptible to infection as they
differentiated into a ciliated phenotype. In addition to infection of ciliated cells via the apical membrane, RSV
was shed exclusively from the apical surface and spread to neighboring ciliated cells by the motion of the cilial
beat. Gross histological examination of cultures infected with RSV revealed no evidence of obvious cytopa-
thology, suggesting that RSV infection in the absence of an immune response can be tolerated for >3 months.
Therefore, rgRSV efficiently transduced the airway epithelium via the lumenal surface and specifically targeted
ciliated airway epithelial cells. Since rgRSV appears to breach the lumenal barriers encountered by other gene
transfer vectors in the airway, this virus may be a good candidate for the development of a gene transfer vector
for CF lung disease.
Human respiratory syncytial virus (RSV) is the most impor-
tant viral agent causing serious pediatric respiratory disease
worldwide (5). RSV infection causes common-cold-like symp-
toms that progress to lower respiratory tract disease in 25 to
40% of infected infants and results in hospitalization for 0.1 to
1.0% of those infected. Almost everyone has been infected by
RSV by 2 years of age. The immunity induced by RSV infec-
tion typically is incomplete, and reinfection is common, al-
though subsequent infections are partially restricted and the
disease severity is reduced (5).
There is a relative lack of direct, detailed information on the
characteristics of RSV infection, spread, and pathology in the
upper and lower respiratory tract of humans. RSV infects the
superficial layer of the respiratory epithelium and has the ca-
pacity to spread throughout the conducting airways. However,
the details of RSV infection remain unclear, including whether
there is a cell specificity to infection, the extent of virus infec-
tion and its relationship to disease manifestation and severity,
the extent and cause of tissue damage, and whether the for-
mation of syncytia that are so prominent in nonpolarized cells
is important for the pathogenesis observed in vivo.
RSV is an enveloped, nonsegmented, negative-sense RNA
virus classified in the subfamily Pneumovirinae of the family
Paramyxoviridae. When propagated in established cell lines,
RSV has been visualized as pleomorphic spheres 120 to 300
nm in diameter and, more frequently, as long filaments of up to
1 to 10 m in length (5, 34). RSV replicates relatively ineffi-
ciently in vitro, and most of the progeny virus remain cell
associated (5, 22). In contrast, RSV replicates to relatively high
titer in the respiratory tract of a permissive host, such as chim-
panzee and human (5). Like those of other members of the
family Paramyxoviridae, RSV gene expression and replication
appear to be entirely cytoplasmic, with no apparent direct
nuclear involvement. The 15.2-kb RNA genome has been com-
pletely sequenced and has been shown to contain 10 mRNAs
encoding 11 distinct proteins, and one or more functions have
been identified for most of the viral proteins. Complete infec-
tious recombinant virus has been rescued from plasmids en-
coding a complete positive-sense copy of the genome together
with the proteins of the nucleocapsid-polymerase complex,
namely, the nucleocapsid (N) protein, phosphoprotein (P),
large polymerase protein (L), and transcription antitermina-
tion factor (M2-1) (6).
RSV encodes three virion surface proteins: the heavily gly-
cosylated G protein, which was previously identified as an
attachment protein (23); the fusion (F) protein, which medi-
ates membrane fusion at the cell surface, resulting in viral
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penetration; and the SH protein, which does not appear to be
necessary for any step in the virus replicative cycle and whose
function remains unknown. An RSV variant called cp-52 that
was derived by extensive passage of wild-type virus in vitro was
shown to lack the SH and G genes due to a spontaneous
deletion (18), and recombinant viruses have been developed
that lack the G gene, the SH gene, or both (4, 36). The ability
of these G deletion RSV mutants to replicate efficiently in
cultured cells (18, 36) indicated that the G protein, like SH, is
also dispensable for infection, syncytium formation, and virion
morphogenesis, at least in vitro. This observation suggested
that the F protein, the sole remaining viral surface protein, can
also act as an attachment protein (3, 36). The RSV envelope
protein-target cell interaction has been studied predominately
in nonpolarized immortal epithelial-cell-like cell lines. Recent
studies have suggested that sulfated glycosaminoglycans on the
membranes of such cell lines are involved in RSV infection (12,
13, 21, 24). Both the G and F proteins have been shown to bind
to heparin, a model glycosaminoglycan (9), consistent with the
idea that each protein might function in attachment. In polar-
ized Vero cell monolayers, RSV infection was shown to result
in the budding and release of virus from the apical surface (34).
In the present study, we characterized RSV infection of
human airway epithelium (HAE) cells using a model of well-
differentiated (WD) HAE. WD HAE cultures are derived di-
rectly from HAE tissue and, following seeding in vitro, grow to
establish a multilayered, polarized, and differentiated tissue
culture that closely resembles the airway epithelium in vivo
with regard to morphology and functions, including mucus
production and ciliary motion (25, 31). RSV infection was
performed using a recombinant RSV that expresses green flu-
orescent protein (GFP) (rgRSV), providing the means to vi-
sualize infection of living cells (36). Our studies show that RSV
preferentially targets the ciliated cells of the airway epithelium
and that infection (and subsequent virus release) occurs exclu-
sively via the apical surface. In addition, RSV infection persists
in this tissue model for 1 month without obvious cytopathic
effects at the light microscopic level, whereas in contrast, in-
fection with influenza A virus results in rapid and extensive
obvious cytopathology.
MATERIALS AND METHODS
Viruses. The construction of rgRSV (224) has been described in detail else-
where (13). Briefly, GFP (Life Technologies, Gaithersburg, Md.) was engineered
to be flanked by RSV gene start and gene end sequences and was inserted as the
first, promoter-proximal gene in a full-length cDNA of the wild-type RSV strain
A2 antigenomic RNA. rgRSV was rescued by cotransfecting HEp-2 cells with the
antigenomic plasmid and N, P, M2-1, and L support plasmids and infecting them
with a modified vaccinia virus, MVA-T7, expressing T7 RNA polymerase (42).
Virus stocks were prepared in HEp-2 cells and were aliquoted and stored at
80°C until use. For HEp-2 cells, rgRSV was found to replicate to near-parental
titers and to produce syncytia at a rate similar to that of the parental virus.
Recombinant wild-type RSV without GFP (GP1) and a biologically derived RSV
strain (Hep-4) were also used in this study. The Udorn strain of influenza A virus
(A/Udorn/72) was provided by Brian Murphy (National Institute of Allergy and
Infectious Disease) and was propagated in HEp-2 cells in the presence of 0.75 g
of trypsin/ml. Nonreplicating adenoviral vectors expressing GFP (AdVGFP)
were obtained from the University of North Carolina Gene Therapy Vector Core
Facility.
Viruses released into the apical compartment were harvested by adding 200 l
of medium to the apical surface of the culture for 20 min and, after retrieval with
a pipette, combining it with an equal volume of 2 viral stabilizing solution (200
mM MgSO4, 100 mM HEPES, pH 7.5), snap freezing the mixture on dry ice, and
storing it at 80°C. Two hundred microliters of basolateral medium from a total
of 1 ml was retrieved and combined with an equal volume of 2 viral stabilizing
solution as described above. Viral titration was performed as described previ-
ously and corrected for differences in sample volume (27).
WD HAE cell culture. Human nasal, tracheobronchial, and bronchiolar airway
epithelial cells were obtained from cystic fibrosis (CF) patients and non-CF
patients undergoing surgical procedures, and epithelial cells were isolated by the
University of North Carolina Cystic Fibrosis Center Tissue Culture Core Facility
using Institutional Review Board-approved protocols. Following enzymatic dis-
persion, cells were seeded on collagen-coated, semipermeable membrane sup-
ports (Transwell-Col; 12 mm in diameter; 0.4-m pore size; Corning-Costar,
Corning, N.Y.) as previously described (31). At confluence, the apical medium
was removed and the cells were maintained at an air-liquid interface (ALI) to
allow differentiation of the epithelial subtypes. WD cultures, identified as cul-
tures containing ciliated cells and with transepithelial resistances of 300 ·cm2,
were studied approximately 4 to 6 weeks after initiation of an ALI unless
otherwise stated. In some cases, primary cells were further expanded on tissue
culture dishes before being seeded onto Transwells (passage 1 cells). Both
primary and passage 1 cultures derived from non-CF and CF sources were used
in the study and showed no significant differences in any of the parameters
tested.
Viral inoculation of HAE cultures. Frozen aliquots of rgRSV or AdVGFP
were thawed immediately before use and diluted in tissue culture medium. After
the apical surfaces of HAE cultures were rinsed with medium, 100 l of viral
suspension was applied to the apical surface for 1 h at 37°C, and the virus was
removed by washing with medium. Inoculation of the basolateral surface of the
cultures was performed by inverting the insert and exposing the permeable
support to a volume and a concentration of virus equal to those used for the
apical inoculation.
For experiments with RSV antibody and ribavirin, the reagents were diluted in
tissue culture medium immediately before use. Antibody (250 g/ml) was ap-
plied to the apical or basolateral surfaces of cultures at the time of rgRSV
inoculation or as otherwise noted. Ribavirin was added to the basolateral me-
dium at a final concentration of 100 g/ml.
Photomicrographs of GFP-expressing cells were acquired using a Leica Leitz
DM IRB fluorescence inverted microscope equipped with a Hamamatsu C5810
color 3 chilled charge-coupled device digital camera and Adobe Photoshop.
Quantitation of infected cells was performed with the image-processing toolkit
plug-ins for Photoshop (ISBN 1-928808-00-X).
Immunolocalization of ciliated-cell-specific KS. Keratan sulfate (KS) immu-
nolocalization was performed with HAE cultures fixed with 4% paraformalde-
hyde. The apical surfaces of cultures were directly exposed to 10% normal goat
serum to block nonspecific attachment prior to addition of a KS-specific mono-
clonal mouse immunoglobulin G (IgG) antibody (MAB2022; Chemicon, Te-
mecula, Calif.), followed by goat anti-mouse IgG-conjugated to Texas Red (Jack-
son ImmunoResearch, West Grove, Pa.). Texas Red fluorescence was recorded
by optical sections using confocal laser scanning microscopy (Leica DM IRBE).
Reagents. Humanized monoclonal antibody directed to the F protein of RSV
(Synagis) was obtained as a kind gift from MedImmune Inc. (Gaithersburg,
Md.). Ribavirin was purchased from ICN Biochemicals Inc. (Aurora, Ohio). All
other reagents and chemicals, unless otherwise noted, were obtained from Sigma
Chemical Company (St. Louis, Mo.).
RESULTS
Polarity of rgRSV infection in HAE cultures. We previously
used rgRSV to monitor infection of HEp-2 cell monolayers, in
particular to characterize the involvement of cell surface gly-
cosaminoglycans in virus attachment and infection in vitro (12,
13). In the present study, we used rgRSV to monitor infection
of WD HAE cultures. These cultures are polarized and
pseudostratified, with mucociliary cells at the apical surface,
similar in both morphology and cell type distribution to the
respiratory epithelium in vivo. The pseudostratified mucocili-
ary epithelial cultures are composed of a number of different
cell types, including lumen-facing ciliated cells, mucus-secret-
ing cells, and intermediate and basal cell types in the basolat-
eral compartment. Figure 1A shows a light photomicrograph
of a cross section of a WD HAE culture, illustrating the
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pseudostratified mucociliary epithelium with abundant ciliated
cells. Approximately 25% of the total cells within a culture are
lumenal cells. Confocal fluorescence optical sectioning of cul-
tures probed with antibody to KS followed by a Texas Red-
conjugated secondary antibody specifically identified the cilia
of ciliated columnar airway epithelial cells (Fig. 1B).
Using this culture system, access to the apical and/or baso-
lateral surface of the epithelium allowed investigation of
whether rgRSV can infect the HAE via either surface. HAE
cultures were inoculated with rgRSV (7  106 PFU; multiplic-
ity of infection [MOI], 20) applied to either the apical or
basolateral surface for 1 h, washed, incubated for a further
24 h, and examined by fluorescence microscopy en face to
detect expression of GFP as an indication of rgRSV infection.
rgRSV infected HAE cells with high efficiency following inoc-
ulation of the apical surface, whereas inoculation of the baso-
lateral surface resulted in little or no infection (Fig. 2). In
contrast, as previously reported, AdVGFP (108 PFU; MOI,
300) applied to the apical surface resulted in no GFP expres-
sion, whereas application to the basolateral surface resulted in
efficient gene transfer.
Since RSV is pleomorphic and can vary in size, the possibil-
ity existed that the pore size of the Transwell-Col membrane
support (0.4 m) might restrict RSV access to the basolateral
surfaces of the cultures. To investigate this possibility, we fil-
tered rgRSV through 0.4-m-pore-size Transwell-Col mem-
brane supports positioned above the apical surfaces of WD
HAE cultures. The efficiencies of rgRSV infection were similar
whether rgRSV was applied directly to the apical surface or
passed through the membrane support (data not shown), in-
dicating that the inability of rgRSV to infect via the basolateral
surface was not due to pore size restriction of the membrane
support. These results show that rgRSV efficiently infects WD
HAE cells via the apical but not the basolateral surface, which
is the direct inverse of the polarized gene transfer character-
istics of AdV.
For culture preparations from 10 different donors treated
with the highest dose of rgRSV (7  106 PFU; MOI, 20), a
range of infection efficiencies was observed (30 to 80% of cells
infected), with an average overall efficiency of 52%. These
data show that in this model of HAE, rgRSV is able to effi-
ciently infect epithelial cells via the lumenal (apical) mem-
brane, but they suggest that not all of the luminal cells were
readily infected.
rgRSV specifically infects ciliated cells of the apical surface.
In order to identify the cell types infected by rgRSV, HAE
cultures were inoculated via the apical or basolateral surface
with rgRSV as described above, incubated for 24 h, immuno-
stained for KS, and visualized by confocal optical sectioning.
Figure 3 shows that rgRSV-mediated GFP expression was lo-
calized to lumenal-surface columnar cells. Furthermore, the
cells infected by rgRSV represented the ciliated subpopulation
of lumenal cells. Although not every ciliated cell in a particular
culture was infected by rgRSV, probably due to a limitation of
rgRSV titer, those that were infected were exclusively ciliated
cells. Basolateral inoculation of rgRSV resulted in little or no
GFP expression in any cell type within the epithelium (0.01%
of cells). In contrast, parallel studies with AdVGFP revealed
an absence of GFP expression following inoculation of the
apical surface, whereas efficient expression was observed fol-
lowing basolateral inoculation, with basal cells as the prefer-
ential target cell type for AdV, as previously reported (31).
These data suggest that, in an intact epithelium, rgRSV pref-
erentially targets ciliated cells of the apical surface.
The results presented above indicated that the cell layer at
the basal surface is refractory to rgRSV infection while the
ciliated cells of the lumenal surface are readily infected. It was
of interest to determine whether other cell types, e.g., inter-
FIG. 1. Cell morphology and KS expression at the apical ciliated surfaces of WD HAE cell cultures. (A) Light micrograph of a cross section
of a WD HAE culture grown at an ALI on a semipermeable membrane support for 4 weeks. Under these conditions, pseudostratified mucociliary
epithelial cell morphology was generated. The cells were counterstained with hematoxylin and eosin. (B) Confocal fluorescent optical section of
a live WD HAE culture exposed to an antibody specific for KS and detected with a secondary antibody conjugated to Texas Red. Note that KS
serves as a marker for ciliated columnar epithelial cells at the apical surface of the culture and that the permeable support, a 10-m-deep layer
underlying the basal epithelial cells, displays non-KS-specific autofluorescence. Original magnification, 100.
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mediate cells, within the multilayer WD HAE cultures could
also be infected with rgRSV. This possibility was evaluated
using an epithelium injury model that allows lumenally applied
virus to reach underlying intermediate and basal epithelial
cells. WD HAE cultures were mechanically injured with a
pipette tip, followed immediately by inoculation with either
rgRSV or AdVGFP on the apical surface for 1 h. The cultures
were then incubated for 24 h, immunostained for KS, and
visualized en face. As shown in Fig. 4, rgRSV infection oc-
curred only in intact apical regions of the epithelium, coinci-
dent with KS staining, with few GFP-expressing cells present in
the region of injury. In contrast, cultures inoculated with Ad-
VGFP were transduced only within the region of injury, where
basal cells were exposed. Thus, nonlumenal airway epithelial
cells (basal and intermediate cells) exposed by mechanical
damage were confirmed to lack KS, as expected, and were not
susceptible to infection by rgRSV. In contrast, as described
previously, HAE cells that underwent mechanical damage
were readily infected by AdVGFP.
To further test the effect on rgRSV infection by disturbing
the integrity of the lumenal cell layer, the epithelial cell tight
junctions were transiently opened by the transient application
of EGTA (10 mM) to the apical surface to allow virus access to
the basolateral membranes of the cells. This treatment has
been shown to produce a significant increase in AdV-mediated
gene transfer, since opening the tight junctions allows access of
AdV to basolaterally located receptors (7, 38). No differences
were observed in the efficiency of rgRSV infection or in the cell
type infected by rgRSV between cultures that maintained in-
tact tight junctions and those in which tight junctions were
transiently opened (data not shown). In sum, these results
indicate that rgRSV specifically targets the apical surfaces of
ciliated airway epithelial cells and that this tropism is not based
on physical accessibility required for entry.
We also examined whether cultures generated from proximal
and distal airway regions were also susceptible to rgRSV infec-
tion. For cultures prepared from nasal, tracheobronchial, and
bronchiolar epithelium, rgRSV exhibited the pattern of infecting
ciliated lumenal cells (data not shown). These results suggest that
all regions of the conducting airway epithelium are susceptible to
infection by rgRSV and that at each location rgRSV preferen-
tially, and perhaps exclusively, infects ciliated cells.
FIG. 2. Comparison of the abilities of rgRSV and AdVGFP to infect the apical (Ap) versus the basolateral (Bl) surfaces of WD HAE cultures.
rgRSV (7  106 PFU; MOI, 20) or AdVGFP (108 PFU; MOI, 300) was applied to either the apical or basolateral surface of the cultures as
detailed in Materials and Methods. Twenty-four hours later, the cultures were analyzed en face for GFP expression by fluorescence photomi-
croscopy. Original magnification, 10.
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Susceptibility of HAE cultures to rgRSV infection requires
differentiation and is coincident with ciliogenesis. We and
others have previously shown that the apical surfaces of WD
HAE cultures are resistant to AdV-mediated gene transfer
because the receptors required for AdV entry are absent from
the apical surfaces of airway epithelia (31, 44). However,
poorly differentiated (PD) HAE cultures, which are confluent,
immature cultures that are precursors to WD HAE, can be
transduced by AdV with high efficiency due to the availability
of AdV receptors and uptake mechanisms (31). To determine
whether the HAE differentiation state affected susceptibility to
rgRSV infection, we applied rgRSV to cultures at different
stages in the differentiation process under otherwise identical
conditions. PD HAE cultures that were inoculated with rgRSV
had no evidence of GFP expression 24 to 48 h later (data not
shown), indicating that these cells are not susceptible to rgRSV
infection. In other cultures, after the establishment of an ALI,
susceptibility to apical infection with rgRSV was evaluated as a
function of time. As shown in Fig. 5A, very few cells were
susceptible to infection on day 2, whereas susceptibility in-
creased substantially by day 6, reaching a maximum on day 14.
Interestingly, susceptibility to infection correlated with cilio-
genesis of the columnar cells of the apical surface (Fig. 5B).
These results indicate that rgRSV infection is differentiation
dependent and that the extent of infection is directly related to
the presence of ciliated columnar epithelial cells.
rgRSV infection, spread, and shedding occur at the apical
surfaces of HAE cultures. Since rgRSV infects ciliated cells via
the apical membrane, we investigated whether rgRSV was
shed from the apical and/or basolateral surfaces of WD HAE
cultures. The apical surfaces of cultures were inoculated with
rgRSV, and infection was allowed to proceed over the follow-
ing 7 days. On each day postinoculation, samples derived from
either the apical or basolateral surfaces were obtained, and the
amount of rgRSV in these samples was determined by stan-
dard titration on HEp-2 cells. For six individual cultures sam-
pled for 7 days, in all cases rgRSV was shed only from the
apical surfaces, as shown in Fig. 6. Within the limits of detec-
tion, no rgRSV was shed from the basolateral surfaces of HAE
cultures. These data indicate that both the initial infection and
subsequent virus shedding for rgRSV are polarized to the
apical surfaces of ciliated cells in HAE.
To monitor the time course of rgRSV infection of WD HAE
cells, cultures were inoculated at the apical surface with a small
amount of virus (7  103 PFU), and fluorescence photomicro-
graphs were taken en face at 1-day intervals to visualize GFP
expression. At 24 h postinoculation, rgRSV infection resulted
in a small number of individual green cells, as shown in Fig.
7A. The spread of rgRSV infection in the cultures over the
next 24 h showed a vectorial pattern radiating from each focal
infection point, forming a circular pattern of infection (Fig.
7B). This pattern was consistent with the pattern of ciliary
movement in these cultures. Over the next 48 h, rgRSV repli-
cation and spread led to a large proportion (80%) of infected
cells (Fig. 7D).
These observations suggest that rgRSV buds from the apical
surface and is released into the lumenal periciliary fluid and/or
FIG. 3. Polarity of rgRSV infection of WD HAE cultures. Shown are confocal fluorescent-optical-section photomicrographs of HAE cultures
inoculated via either the apical (Ap) or basolateral (Bl) surfaces with rgRSV or AdVGFP. Twenty-four hours after infection, the cultures were fixed
and immunostained with antibody specific for KS and detected by a secondary antibody conjugated to Texas Red. The KS-expressing apical
surfaces of ciliated cells are shown in red, and virus-infected cells are shown in green. Original magnification, 63.
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overlying mucus layer. Thereafter, rgRSV is spread vectorially
to adjacent cells within these compartments.
Effects of a neutralizing antibody and ribavirin on rgRSV
infection. We further characterized the model by examining
the effect of two clinically relevant antiviral agents effective
against RSV infection. One agent, Synagis, is a humanized
monoclonal antibody specific to the F protein that efficiently
neutralizes viral infectivity. This antibody approach is currently
in use in passive parenteral immunoprophylaxis in high-risk
infants. The second agent, ribavirin, is a nucleoside analog that
is used clinically as therapy for RSV infection. We tested the
abilities of Synagis and ribavirin to inhibit both initial infection
and subsequent spread of rgRSV in WD HAE cultures.
To determine whether these reagents could inhibit initial
rgRSV infection, the antibody (250 g/ml) was mixed with
virus and applied to the apical surface, whereas ribavirin (100
g/ml) was added to the basolateral medium immediately be-
fore inoculation. As shown in Fig. 8C and D, respectively, both
the antibody and the ribavirin treatments resulted in complete
inhibition of rgRSV infection compared to the control (Fig.
8A). To determine whether antibody and ribavirin were also
able to reduce viral spread in cultures after infection with
rgRSV, either antibody (apical) or ribavirin (basolateral) was
applied 6 or 24 h, respectively, after inoculation of WD HAE
with rgRSV. As expected, infected cells were detected 24 h
postinoculation, but 3 days later there was no evidence of viral
spread for cultures that received either the antibody (Fig. 8F)
or ribavirin (Fig. 8H) treatment, in contrast to the rapid spread
of rgRSV in the untreated cultures (Fig. 8B). Removal of
antibody or ribavirin from the respective cultures allowed the
resumption of rgRSV spread within 48 h (results not shown).
Additional experiments were performed to determine
whether the anti-F antibody inhibited rgRSV infection and
spread when the antibody was exposed to the basolateral
FIG. 4. Effect of mechanical damage to the epithelium of WD HAE cultures on rgRSV and AdVGFP infection. WD HAE cultures were
scratched with a pipette tip across the apical surface to expose the underlying basal cells along the injury path (white lines). The apical surfaces
of injured cultures were immediately inoculated with rgRSV or AdVGFP as for Fig. 2; 24 h later, the cultures were fixed and immunostained with
antibody to KS, and the cultures were examined en face by fluorescence photomicroscopy. Note that in the left panel few cells expressed GFP
within the injury path, while the undamaged regions colocalized with both GFP and KS expression, reflecting the presence of rgRSV infection and
ciliated cells, respectively, in this region. In contrast, in the right panel the injury tract expressed GFP, reflecting AdVGFP infection, but did not
colocalize with the undamaged tissue that expressed KS, reflecting the presence of intact ciliated cells. Original magnification, 10.
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FIG. 5. Susceptibility of HAE cultures to rgRSV infection as a function of the differentiation state of the culture. (A) Freshly plated cells were grown
to confluence to represent a PD cell type and allowed to differentiate with time. On the indicated days following establishment of an ALI, replicate
cultures were inoculated with rgRSV (7  106 PFU), and the percentage of GFP-positive cells was quantitated by fluorescence photomicroscopy 24 h
later. Each datum point represents the mean of three independent measurements 	 standard error of the mean. (B) Representative photomicrographs
of the differentiation status of HAE cultures on day 2 (i), day 8 (ii), and day 14 (iii) after initiation of an ALI. Note the abundant ciliated cells on day
14. The cells were counterstained with hematoxylin and eosin. Also shown are en face fluorescence photomicrographs of corresponding cultures
expressing GFP 24 h after inoculation with rgRSV on day 2 (iv), day 8 (v), and day 14 (vi). Original magnifications, 100 (light) and 10 (fluorescence).
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rather than the apical surface. Antibody applied to the ba-
solateral surface either at the time of or 24 h prior to rgRSV
inoculation was not effective in reducing the infection or
spread of rgRSV compared to control cultures (results not
shown). These data illustrated the efficacy of these clinical
strategies to reduce the infectivity of RSV in a model of
HAE. In particular, these experiments illustrated that anti-
body applied to the luminal surface efficiently gained access
to the local site of infection so that all viral spread was
inhibited. These data are consistent with the efficacy of
Synagis given parentally but point to the requirement for
antibody to reach apical compartments in order to be effec-
tive therapeutically.
Persistence of rgRSV in HAE without obvious cytopathol-
ogy. In general, the number of cells expressing GFP in WD
HAE cultures peaked 2 to 3 days after initial infection, fol-
lowed by a decrease in the number of positive cells over the
next 36 days to a level approximately 25% of that at day 3, at
which point the number of infected cells stabilized.
An example of GFP expression 36 days after rgRSV inocu-
lation is shown in Fig. 9A. For periods of up to 3 months, the
FIG. 6. Polarized release of rgRSV from the apical surfaces of WD
HAE cultures. Virus shed from either the apical or basolateral surfaces
of six independent cultures was collected at 24 h intervals as described
in Materials and Methods. Titration of the collected samples on HEp-2
cells revealed significant shedding of rgRSV from the apical surface
(diamonds), whereas within the limits of detection, no viral shedding
was measured from the basolateral surface (below limits of detection).
The values shown represent the mean 	 standard deviation (n 
 6).
FIG. 7. Spread of rgRSV infection with time in WD HAE cultures. The apical surfaces of cultures were inoculated with a low titer of rgRSV
(7 103 PFU) to achieve a submaximal number of cells expressing GFP at 24 h. Infection was then allowed to proceed over 4 days, and GFP
expression was examined en face by fluorescence photomicroscopy on days 1 (A), 2 (B), 3 (C), and 4 (D) postinoculation. Note the counter-
clockwise circular spread of rgRSV infection by day 2 (B) and the increased number of rgRSV-infected cells by day 4. Original magnification, 10.
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FIG. 8. Inhibition of initial rgRSV infection and spread in WD HAE cultures with an RSV-neutralizing monoclonal antibody or ribavirin. The apical
surfaces of HAE cultures were inoculated with rgRSV (105 PFU; MOI, 0.3), and GFP expression was monitored en face by fluorescence photomi-
croscopy 1 (A) and 3 (B) days later. To assess the effects of potential RSV inhibitors on initial rgRSV infection, parallel cultures were treated prior to
rgRSV inoculation with either 250 g of the F-specific RSV-neutralizing monoclonal antibody Synagis/ml applied to the apical surface (C) or 100 g of
ribavirin/ml included in the basolateral medium (D). The cultures were then inoculated with rgRSV as described above, and GFP expression was assessed
1 day later by fluorescence photomicroscopy. To assess the effects of RSV inhibitors on viral spread, parallel cultures were inoculated as described above
and then treated with Synagis 6 h postinoculation, and GFP expression was assessed on day 1 (E) and day 3 (F) postinoculation. Cultures treated with
ribavirin 24 h postinoculation were assessed for GFP expression by fluorescence photomicroscopy on day 2 (G) and day 4 (H) postinoculation. Original
magnification, 10.
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longest interval studied, at the light microscope level, the his-
tological integrity of rgRSV-infected cultures was not detect-
ably altered compared to uninfected cultures from the same
source. Specifically, cells appeared to be normal following
rgRSV infection, there was no syncytium formation, and the
cilial beat was visually unaltered. Histological examination of
cultures infected by rgRSV for more than a month revealed no
gross histological differences and, importantly, no cell fusion or
syncytium formation (Fig. 9B). We also infected WD HAE
with a wild-type recombinant RSV that lacks the GFP gene
(GP1), the direct parent of rgRSV, and with biologically de-
rived wild-type RSV (Hep-4). Over a period of 36 days, these
FIG. 9. Lack of RSV-specific obvious cytopathology in WD HAE cells. (A) Confocal optical section of rgRSV-mediated GFP expression 36
days after apical inoculation of a WD HAE culture with rgRSV (7  106 PFU). GFP expression (green) was predominately in ciliated cells, as
shown by colocalization with KS-specific antibodies (apical red signal). Note the lack of cell-cell fusion, i.e., syncytium formation. Original
magnification, 63. (B) No obvious cytopathology of different RSV isolates was observed after apical inoculation of WD HAE cultures. The apical
surfaces of HAE cultures were inoculated with either rgRSV (106 PFU); GP1, an isogenic recombinant RSV that lacks GFP (106 PFU); Hep-4,
a biologically derived wild-type RSV (106 PFU); or the Udorn strain of influenza A virus (106 PFU). The RSV- and influenza virus-inoculated
cultures were incubated for 37 and 2 days, respectively. Histological cross sections counterstained with hematoxylin and eosin showed no gross
histological differences in cell morphology for the RSV-inoculated cultures compared to cultures not inoculated with any virus. In contrast, cultures
inoculated with influenza A virus underwent significant cytopathology 2 days postinoculation. Original magnification, 63.
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cultures also failed to display obvious cytopathology (Fig. 9B).
In contrast, cultures infected with influenza A virus (Udorn
strain) exhibited dramatic, rapid destruction and shedding of
the columnar airway epithelial cells, as has been observed in
vivo (14, 15, 41).
These data indicate that RSV, unlike influenza A virus, does
not produce obvious cytopathology in airway epithelial cul-
tures in the absence of a host immune response and suggest
that in vivo, the pathogenic nature of RSV infection might in
large part be mediated by the host immune response.
DISCUSSION
We have investigated RSV infection in a model of primary
WD HAE cells by using a recombinant RSV that expresses
GFP to monitor RSV infection in living cells. We found that
rgRSV primarily, perhaps exclusively, targets the lumenal cil-
iated columnar airway epithelial cells via the apical surfaces of
the cultures. In contrast, rgRSV infection was not observed
after basolateral inoculation and was not enhanced by disrup-
tion of epithelial tight junctions or by mechanical damage to
the tissue. These observations suggest that basal cells and the
basolateral surfaces of columnar cells are not permissive for
rgRSV infection. Progeny rgRSV were released from the api-
cal surfaces of WD HAE cultures, and rgRSV infection spread
via the lumenal surface to neighboring ciliated cells. A previ-
ous study showed that RSV was released from the apical mem-
branes of polarized Vero cell monolayer cultures (34). How-
ever, since these cells are not derived from human tissue, are
not ciliated, are immortalized, and form a single monolayer, it
was important to confirm and extend these results in a primary,
differentiated, multilayered, ciliated HAE culture. An interest-
ing finding, only possible in a culture model such as that used
in the present study, was that virus spread in HAE cells ap-
peared to be affected by the directionality of the cilial beat. The
ciliary beat has been shown to direct the movement of the
periciliary fluid as well as the overlying mucus in this culture
model (26).
A striking observation was that rgRSV appeared to primarily,
and perhaps exclusively, infect ciliated cells. This was not only
true in WD cultures but was also observed in immature HAE
cultures undergoing differentiation, where susceptibility to rgRSV
infection was dependent on differentiation and coincident with
ciliogenesis. This may mean that the cilia themselves are directly
necessary for rgRSV infection and might, for example, be the site
of viral attachment. A direct role of cilia in RSV infection would
be an important difference from infection of established cell lines,
such as HEp-2 cells, which are highly permissive to RSV but are
not ciliated. Even if cilia are not directly involved with RSV
infection, the maturational requirement of primary HAE cells for
susceptibility to rgRSV infection is interesting and contrasts with
the ability of RSV to infect many established cell lines. One
possibility is that infection of established cell lines proceeds by an
alternative pathway, one that might not be representative of that
which occurs for the airway epithelium in vivo. For example, it will
be of interest to test whether the requirement for glycosamino-
glycans for efficient RSV infection of established lines, such as
HEp-2 cells, is also a requirement in the WD HAE cultures. WD
HAE cultures likely will be the cell model of choice for examining
the mechanisms of virus-host cell interactions important for ini-
tiating RSV infection, at least for the airway epithelium.
RSV infection initiates in the upper airway regions, after
which the virus can spread to more distal airway regions and to
the alveoli (11). Our data indicate that the characteristics of
infection are similar for epithelial cell cultures derived from
upper and lower airway epithelia, specifically the nasal, tra-
cheobronchial, and bronchiolar regions. We did not test the
ability of rgRSV to infect cells of the alveolar region, and thus,
the observations that we describe apply strictly to the epithe-
lium of the conducting airways. We found that for culture
models from these airway regions, the extent of infection cor-
related with the number of ciliated cells present in the culture.
Although ciliated cells of the upper airways differ in height and
length of the cilial shaft from ciliated cells of the bronchioles,
we found that both upper and lower ciliated cell types were
susceptible to rgRSV infection.
Two clinical strategies currently in use against RSV infec-
tion, namely, an anti-F protein monoclonal antibody used in
pediatric immunoprophylaxis and the nucleoside analog riba-
virin used in RSV therapy (33), were efficacious against rgRSV
infection in WD HAE cultures. Our experiments emphasized
important aspects of the polarity of airway epithelium. The
antibody was only effective at preventing rgRSV spread when
presented on the apical surface. This finding suggests that
trans-epithelial cell transport of this IgG antibody from the
basolateral to the apical compartment was not efficient in vitro,
at least not within the incubation period studied. It is also
consistent with clinical experience: serum IgG antibodies are
inefficiently transported to the lumenal surface of the respira-
tory tract, and RSV-neutralizing serum antibodies restrict RSV
infection only when present at high titer (10, 32). In contrast,
ribavirin was active with basolateral application mimicking pa-
rental administration in vivo. The ability of ribavirin to strongly
inhibit RSV replication in vitro had been shown previously
with nonpolarized cells (16). In the present work, the strong
inhibition of GFP expression observed with ribavirin, added
immediately before virus inoculation, shows that this nucleo-
side analog readily achieved bioavailability and greatly re-
stricted gene expression. In addition, ribavirin acts early in the
viral infection cycle, greatly restricting viral gene expression in
addition to blocking the spread of infection.
An interesting finding of the present study was the observa-
tion that GFP expression was maintained in WD HAE cultures
for up to 3 months, the longest period during which the cul-
tures were maintained. It is not known whether the GFP-
expressing cells observed after 3 months were ones that had
been infected at the outset and maintained throughout the
entire period or whether there was turnover of cells and rein-
fection of newly differentiated ciliated cells. Since the half-life
of ciliated airway cells in these cultures has been estimated to
be on the order of 40 to 100 days (1), it seems likely that some,
and perhaps most, of the cells observed at 3 months were not
among the infected cells present during inoculation. It is un-
known whether rgRSV infection alters the half-life of ciliated
airway cells in this culture system. However, it is clear that
rgRSV infection produced little or no virus-specific obvious
cytopathic effect in WD HAE cells. In particular, there was no
evidence of syncytium formation in either columnar, interme-
diate, or basal cells. Thus, while rgRSV infection might have
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subtle effects that were undetected, such as altering cellular
half-life or inducing apoptosis, on a gross level rgRSV infec-
tion in this model of WD HAE was noncytopathic. We con-
firmed that this was not an artifact of rgRSV, since similar
results were obtained with its wild-type recombinant parent
lacking GFP as well as with a biologically derived wild-type
RSV. The last two viruses have been shown to cause respira-
tory disease in chimpanzees, confirming that they are wild-type
viruses (40).
In contrast to rgRSV, influenza A virus infection of WD
HAE cultures resulted in rapid and extensive obvious cytopa-
thology. This is consistent with clinical pathological findings
that influenza virus infection results in extensive damage to the
respiratory epithelium in infected humans (14, 15). These find-
ings suggest that the tissue damage that is observed in the
ciliated airway epithelium in vivo in response to RSV infection
might not be due directly to viral presence and growth but
rather is a consequence of destructive components of a robust
immune response that eventually clears the virus infection. The
situation was very different with influenza A virus, where virus
infection was inherently highly cytopathic even in the absence
of an immune response. Since we did not examine rgRSV
infection in a system that corresponds to the alveolar epithelial
region, it is possible that viral cytopathology might be different
in that compartment.
The observed absence of obvious cytopathology by RSV
infection in our culture model is in contrast to a previous
report that also used a polarized, ciliated HAE cell culture
model to assess the effect of wild-type RSV infection (37). In
that study, RSV infection was found to have multiple effects:
(i) lumenal cilial beat frequency was significantly inhibited
within 2 h of virus addition to the lumenal surface, (ii) loss of
cilia occurred 24 h after infection, (iii) syncytia formed, and
(iv) all ciliated cells were sloughed from the culture by 3 to 5
days postinfection. Under similar conditions with our culture
system, we did not observe any of these effects with rgRSV or
with a wild-type RSV. The differences between these studies
remain to be explained and may involve differences in the virus
or cell culture systems used.
The lack of obvious RSV cytopathology with the HAE culture
system described in this study is probably related to the lack of
syncytium formation. Most studies of RSV have been performed
with nonpolarized epithelial cell lines (e.g., HEp-2) that undergo
cell-cell fusion 2 to 5 days after exposure to RSV and ultimately
undergo cell death. However, using our polarized WD HAE
model, no syncytia were ever observed. In vivo, syncytia have not
been a prominent pathological feature of RSV infection, al-
though they have been observed in autopsy tissue from RSV-
infected patients (28), and RSV can cause giant-cell pneumonia
in immunocompromised individuals (8). It might well be that, like
our WD HAE cultures, the epithelium of the airways is refractory
to syncytium formation and that which is observed in vivo involves
the alveolar epithelium. In a study with the polarized epithelial
cell line Vero C1008, Roberts et al. (34) reported that RSV
matured at the apical surface without syncytium formation. They
also found the F protein preferentially expressed at the apical
surfaces of RSV-infected polarized cell monolayers, and it seems
likely that the same is true of the multilayer HAE cultures in the
present work. If the F protein is distributed exclusively at the
apical surface, its interaction with adjacent cells likely would be
restricted, and therefore the formation of syncytia would be sup-
pressed. This segregation might not be an all-or-none phenome-
non, as suggested by the data of Roberts et al. The efficiency of
polar segregation might be further compromised under certain
conditions and could be responsible for the syncytium formation
observed by Tristram et al. (37). It also might be that the efficiency
of polar segregation could be rendered less efficient in vivo, per-
haps during an immune attack, which could account for the syn-
cytia that are sometimes observed in vivo.
The ability of RSV to transfer genes to the ciliated cells of the
airway epithelium after lumenal delivery indicates that this virus
may provide a new vector system suitable for disorders of the lung
epithelium, such as CF lung disease. In the case of CF, the ciliated
airway epithelial cells are considered to be the target cell type that
requires correction (2, 17, 20, 29). So far, gene therapy strategies
have investigated vector systems such as adenovirus types 2 and 5,
adeno-associated virus type 2, and retroviruses, none of which
efficiently transfer genes to the lumenal columnar airway epithe-
lial cells. The inefficiency of gene transfer is reported to be due to
a number of barriers that are present at the apical surface of the
lung epithelium, most notably the absence of receptors for the
specific viruses from the apical surfaces of the cells (31, 44) and
the presence of a restrictive glycocalyx barrier (30). For RSV,
neither of these potential barriers appears to be restrictive for
efficient infection.
Other vector systems have been reported to deliver genes to
columnar airway cells via the lumenal membrane. Sendai virus
vectors have been shown to infect ciliated cells of the rodent
airway (43), but the efficiency with which this rodent virus
infects HAE cells remains to be determined. Lentiviral vectors
pseudotyped with components of Ebola virus membrane pro-
teins have been shown to efficiently transduce HAE cells in
vitro, suggesting that combining the efficiency of this system
with the potential long duration of lentivirus-mediated gene
expression may provide an effective vector for gene therapy
strategies for the lung epithelium (19, 35). Interestingly, lenti-
virus pseudotyped with RSV F and G proteins did not trans-
duce HAE cells, although there is some question as to the
efficiency of virion formation with this pseudotyping strategy
(19). The present study confirms that RSV indeed targets the
lumenal epithelial cells. Coronavirus (39) and adeno-associ-
ated virus type 5 (45) have also been reported to be efficient for
gene transfer to the lung epithelium. Further studies are re-
quired to determine the efficacies of these vectors for potential
clinical applications.
The high efficiency of RSV infection in WD HAE cultures;
the specificity of infection for the lumenal ciliated cells; the
unexpected long duration of transgene expression, at least in
the absence of an immune response; and the lack of obvious
cytopathology in infected cultures indicate that RSV is an
attractive candidate for further development as a gene transfer
vector to target ciliated airway epithelium. Of course, further
modification of the recombinant virus likely will be necessary
for this application. For example, it will be necessary to use a
version of recombinant RSV that does not cause respiratory
tract disease. Fortunately, a wide array of recombinantly de-
rived attenuated versions of RSV are available, and there is
extensive clinical experience with experimental RSV vaccines
that will aid in the development of vectors suitable for gene
transfer to the lung epithelium.
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